home / stock / a / a news


A News and Press, Agilent Technologies Inc.

Stock Information

Company Name: Agilent Technologies Inc.
Stock Symbol: A
Market: NYSE
Website: agilent.com

Menu

Get A Alerts

News, Short Squeeze, Breakout and More Instantly...

A - ColestZen Official Launch 2026 | Cholesterol Support Capsules Available in USA, UK, CA & AU Market By Colestzen Supplement.

New York City, July 18, 2026 (GLOBE NEWSWIRE) --     In 2026, we announced the launch of ColestZen to support a healthy cholesterol formula, Your Ultimate Partner in Managing Cholesterol and Metabolic Health. We are excited to present ColestZen, a premium capsule-based dietary supple...

A - MDaudit Advances Its Meaningful AI Strategy with the Addition of Auditor Assist to Its Continuous Risk Monitoring Solutions Suite

WELLESLEY, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Payers are denying claims at AI-driven speed, often autoflagging and subsequently denying valid claims for provided care that hospitals and health systems must fight to recover. Benchmark data from MDaudit tells the story: payer audit volume and...

A - Lira Clinical Announces New REGEN Line - A First-of-Its-Kind Breakthrough in Regenerative Skincare 

LIVERMORE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Lira Clinical, a global leader in corrective and brightening skincare, is proud to announce the launch of its groundbreaking new REGEN line. REGEN is the first and only clinical skincare line formulated with Wild Salmon Stem Cell–Cond...

A - Quebec's Real Estate Market Gradually Rebalances in the Second Quarter

L’ÎLE-DES-SŒURS, Quebec, July 14, 2026 (GLOBE NEWSWIRE) -- The Quebec Professional Association of Real Estate Brokers (QPAREB) has just released its residential real estate market statistics for the  province of Quebec , based on the real estate brokers’ Centris pro...

A - Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Test enables identification of patients whose tumors express PD-L1 and who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for ...

A - Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer

$85M upfront financing, along with up to $255 million upon exercise of purchase warrants, is expected to fund ROBBIN 1 , Agenus' registrational Phase 3 trial of neoadjuvant botensilimab and balstilimab (BOT+BAL) in microsatellite-stable (MSS) colon cancer Transaction is structured to fund...

A - Notable healthcare headlines for the week: UnitedHealth, Vertex, and CVS Health in focus

2026-07-12 09:05:05 ET More on State Street Health Care Select Sector SPDR ETF Soft Landing Myth: How This Week's Data Exposed The Hidden Recession Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It AI Revolutionizing Biopharma: Faster, Bette...

A - HSBC's top picks heading into earnings season

2026-07-10 09:18:32 ET More on the Markets It's Time To Buy Gold And Silver Start Investing At 60 And Retire On Dividends Forever Labor Market Frozen, Fed PUT On Ice Diversification wins: 25/25/25/25 portfolio posts best year since 2021 Spike in optio...

A - Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat

2026-07-09 11:07:35 ET Summary Read the full article on Seeking Alpha For further details see: Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat

A - Blackpoint Cyber Unveils New Identity Threat AI SOC Agent to Stop Credential-Based Attacks in Seconds

DENVER, July 08, 2026 (GLOBE NEWSWIRE) -- Blackpoint Cyber today unveiled the first generally available autonomous response capability; Blackpoint AI SOC Agent for Identity Threat Detection and Response (ITDR). Using an AI + human hybrid model, the AI SOC Agent acts on high-confidence threa...

Next 10